Q2 2025 Holdings
Filed 2025-08-14 | 96 holdings | $328.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $23.8M | 284,152 | 7.3% |
| Amgen Inc(AMGN)Put | COM | 031162100 | $17.3M | 62,100 | 5.3% |
| ELI Lilly & Co(LLY)Put | COM | 532457108 | $16.1M | 20,700 | 4.9% |
| Amgen Inc(AMGN) | COM | 031162100 | $14.5M | 52,100 | 4.4% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $13.4M | 371,448 | 4.1% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $11.8M | 94,042 | 3.6% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $11.5M | 14,816 | 3.5% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $11.1M | 104,473 | 3.4% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $10.6M | 192,877 | 3.2% |
| Spdr Series Trust(XBI)Call | S&P BIOTECH | 78464A870 | $8.3M | 100,000 | 2.5% |
| Ultragenyx Pharmaceutical in(RARE)Call | COM | 90400D108 | $7.9M | 217,000 | 2.4% |
| ELI Lilly & Co(LLY)Call | COM | 532457108 | $7.8M | 10,000 | 2.4% |
| Revolution Medicines Inc(RVMD)Call | COM | 76155X100 | $7.4M | 200,000 | 2.2% |
| Corcept Therapeutics Inc(CORT)Put | COM | 218352102 | $7.4M | 100,200 | 2.2% |
| Novo-Nordisk A S(NVO)Call | ADR | 670100205 | $6.9M | 100,000 | 2.1% |
| Apogee Therapeutics Inc(APGE)Call | COM | 03770N101 | $6.8M | 156,300 | 2.1% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $6.4M | 198,285 | 2.0% |
| Bridgebio Pharma Inc(BBIO)Call | COM | 10806X102 | $5.7M | 131,400 | 1.7% |
| Crispr Therapeutics AG(CRSP)Call | NAMEN AKT | H17182108 | $5.4M | 112,000 | 1.7% |
| Jazz Pharmaceuticals PLC(JAZZ)Call | SHS USD | G50871105 | $5.3M | 50,000 | 1.6% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $5.2M | 197,468 | 1.6% |
| ARS Pharmaceuticals Inc(SPRY)Call | COM | 82835W108 | $4.9M | 280,700 | 1.5% |
| Altimmune Inc(ALT)Call | COM NEW | 02155H200 | $4.9M | 1,262,900 | 1.5% |
| Pfizer Inc(PFE)Call | COM | 717081103 | $4.8M | 200,000 | 1.5% |
| Ultragenyx Pharmaceutical in(RARE)Put | COM | 90400D108 | $4.5M | 123,300 | 1.4% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $4.5M | 10,000 | 1.4% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $4.2M | 76,185 | 1.3% |
| Agios Pharmaceuticals Inc(AGIO)Call | COM | 00847X104 | $4.1M | 122,100 | 1.2% |
| Mereo Biopharma Group PLC(MREO)Call | SPON ADS | 589492107 | $3.6M | 1,317,600 | 1.1% |
| Recursion Pharmaceuticals in(RXRX)Call | CL A | 75629V104 | $3.5M | 698,400 | 1.1% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $3.3M | 30,000 | 1.0% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $3.3M | 5,974 | 1.0% |
| Immunocore Hldgs PLC(IMCR) | ADS | 45258D105 | $3.3M | 104,384 | 1.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $2.9M | 5,607 | 0.9% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $2.9M | 79,079 | 0.9% |
| Moderna Inc(MRNA)Call | COM | 60770K107 | $2.8M | 102,100 | 0.9% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $2.8M | 392,213 | 0.9% |
| Moderna Inc(MRNA)Put | COM | 60770K107 | $2.8M | 100,000 | 0.8% |
| Zymeworks Inc(ZYME)Call | COM | 98985Y108 | $2.3M | 179,300 | 0.7% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $2.2M | 62,926 | 0.7% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $2.1M | 206,200 | 0.6% |
| Urogen Pharma LTD(URGN) | COM | M96088105 | $2.1M | 150,000 | 0.6% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $2.0M | 53,985 | 0.6% |
| Moonlake Immunotherapeutics(MLTX)Put | CLASS A ORD | 61559X104 | $1.9M | 41,300 | 0.6% |
| Mannkind Corp(MNKD)Call | COM NEW | 56400P706 | $1.9M | 519,900 | 0.6% |
| Acadia Pharmaceuticals Inc(ACAD)Call | COM | 004225108 | $1.9M | 88,900 | 0.6% |
| Scpharmaceuticals Inc(SCPH)Call | COM | 810648105 | $1.9M | 486,500 | 0.6% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $1.7M | 122,061 | 0.5% |
| Summit Therapeutics Inc(SMMT)Call | COM | 86627T108 | $1.6M | 74,700 | 0.5% |
| Merck & Co Inc(MRK) | COM | 58933Y105 | $1.6M | 20,000 | 0.5% |